Share on StockTwits

CAS Medical Systems (NASDAQ:CASM) CEO Thomas M. Patton bought 10,000 shares of the company’s stock in a transaction dated Monday, August 18th. The shares were purchased at an average cost of $1.54 per share, for a total transaction of $15,400.00. Following the completion of the transaction, the chief executive officer now directly owns 550,177 shares of the company’s stock, valued at approximately $847,273. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

CAS Medical Systems (NASDAQ:CASM) opened at 1.48 on Wednesday. CAS Medical Systems has a 1-year low of $1.211 and a 1-year high of $2.50. The stock’s 50-day moving average is $1.79 and its 200-day moving average is $2.05. The company’s market cap is $28.5 million.

CAS Medical Systems (NASDAQ:CASM) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.02. The company had revenue of $5.80 million for the quarter, compared to the consensus estimate of $5.00 million. On average, analysts predict that CAS Medical Systems will post $-0.48 earnings per share for the current fiscal year.

CAS Medical Systems, Inc (NASDAQ:CASM) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that is vital to patient care.

Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with Analyst Ratings Network's FREE daily email newsletter.